AoFrio advises it has no exposure to Silicon Valley Bank
A: 21 Arrenway Drive, Rosedale, Auckland 0632, New
Zealand PO Box: 302-533 North Harbour, Auckland 0751,
New Zealand
P: + 64 9 477 4500 E: info@aofrio.com
® is a registered Trademark of AoFrio Ltd.
13 March 2023
Market Announcement
For immediate release
AoFrio advises it has no exposure to Silicon Valley Bank
AoFrio Limited (NZX: AOF), advises that it does not have any deposits or other banking
arrangements with Silicon Valley Bank in the United States or elsewhere, or with other similar
banks commonly used by tech and start-up businesses.
Ends
Contact
Greg Balla Howard Milliner
Chief Executive Officer Chief Financial Officer
Phone + 64 21 938 601 +64 27 587 0455
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- AFT — AFT Pharmaceuticals Limited: AFT declares maiden dividend; record revenue2023-05-21
“AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand Incorporated in New Zealand ARBN: ARBN 609 017 969 Results for announcement to the market AFT Pharmaceuticals Limited Reporting Period 12 months to 31 March 2023 Previo…”
- AFT — AFT Pharmaceuticals Limited: 2023 New Year letter to investors2023-01-08
“AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand Incorporated in New Zealand ARBN: ARBN 609 017 969 investor.relations@aftpharm.com We have a number of other projects advancing and regulatory dossiers are now comple…”
- ATM — The a2 Milk Company Limited: a2MC responds to Synlait’s FY23 guidance announcement2023-04-25
“2 Taking all of the above factors noted by the Company into account, a2MC confirms that there is no material change to its FY23 outlook as confirmed at the time of the announcement of its 1H23 results on 20 February 2023. The Company maintains its FY23 revenue guidance of l…”